CASPOFUNGIN Side Effects

6179729-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on May 01, 2009 Male patient from UNITED STATES , 30 years of age, weighting 357.1 lb, was diagnosed with evidence based treatment, fungal infection (What is fungal infection?) and was treated with Caspofungin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased. Caspofungin dosage: 50 Mg Iv Qd. During the same period patient was treated with LINEZOLID (View Linezolid Review and Linezolid Label ), METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), EPOETIN (View Epoetin Review and Epoetin Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PREVACID (View Prevacid Review and Prevacid Label ), SENNA (View Senna Review and Senna Label ), COLACE (View Colace Review and Colace Label ).

6043421-6 | Blood Alkaline Phosphatase Increased
Patient was taking Caspofungin (View Usage). Patient had the following side effects: blood alkaline phosphatase increased on Jan 15, 2009 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 150.0 lb, was diagnosed with candidiasis and. Caspofungin dosage: 50 Mg Q24h Iv. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MORPHINE (View Morphine Review and Morphine Label ), FLAGYL (View Flagyl Review and Flagyl Label ).

5203863-5 | Aspergillosis, Respiratory Distress, Skin Discolouration, Skin Disorder, Swollen Tongue
Adverse event was reported on Jan 05, 2007 by a Male patient taking Caspofungin (View Usage) (Dosage: See Image) was diagnosed with febrile neutropenia and. Location: UNITED STATES , 77 years of age, weighting 160.3 lb, After Caspofungin was administered, patient had the following side effects: aspergillosis, respiratory distress, skin discolouration, skin disorder, swollen tongue. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DIATRIZOATE MEGLUMINE (View Diatrizoate Meglumine Review and Diatrizoate Meglumine Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), COLACE (View Colace Review and Colace Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), MAALOX FAST BLOCKER (View Maalox Fast Blocker Review and Maalox Fast Blocker Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

5140432-X | Haematocrit Decreased
on Oct 26, 2006 Male patient from UNITED STATES , weighting 217.4 lb, was diagnosed with candida pneumonia and was treated with Caspofungin (View Usage). Patient experienced the following unwanted or unexpected effects: haematocrit decreased. Caspofungin dosage: 50mg Daily Iv. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), DOCUSATE (View Docusate Review and Docusate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.


5046070-1 | Hepatotoxicity
on Jul 07, 2006 Male patient from UNITED STATES , 54 years of age, weighting 162.7 lb, was treated with Caspofungin (View Usage). Patient had the following side effects: hepatotoxicity. Caspofungin dosage: .

4864232-0 | Renal Failure
Patient was taking Caspofungin (View Usage). After Caspofungin was administered, patient had the following side effects: renal failure on Dec 20, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 215.2 lb, was diagnosed with fungaemia and. Caspofungin dosage: 70 Mg Once Iv. Patient was hospitalized.

4632846-9 | Arterial Rupture, Fungal Infection, Hyperbilirubinaemia, Liver Function Test Abnormal
Adverse event was reported on Mar 09, 2005 by a Male patient taking Caspofungin (View Usage) (Dosage: 50 Mg, Qd) was diagnosed with fungal infection (What is fungal infection?), acute lymphocytic leukaemia recurrent and. Location: , 42 years of age, Patient experienced the following unwanted or unexpected effects: arterial rupture, fungal infection (What is fungal infection?), hyperbilirubinaemia, liver function test abnormal. During the same period patient was treated with GLEEVEC (600 Mg, Qd) (View Gleevec Review and Gleevec Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CHLORVESCENT (View Chlorvescent Review and Chlorvescent Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).